On July 22, 2014, the Restriction of Hazardous Substances II legislative Directive becomes mandatory for medical devices and monitoring and control equipment placed on the market in the EU. Manufacturers, importers and distributors have specific obligations under this Directive.
This workshop, being held Nov. 19, 2013, at the AdvaMed Headquarters in Washington, D.C., will give attendees a firm understanding of current restricted substance regulations, as well as the process and documentation requirements of the expanded RoHS II legislation such as:
- The Process Requirements
- Determine information needed
- Collect and evaluate
- Periodic reassessment
- The Testing Requirements
- Homogeneous materials
- Historical perspective
- XRF screening
- Destructive analytical tests
- Current standards and evolution
Industry experts will discuss topics that will enable to you learn about key aspects of Restriction of Hazardous Substances, such as:
- Exemptions in the Directive
- Process requirements for compliance – non-destructive and destructive testing
- How to maintain and support ongoing compliance
- Resource needs to support these activities
- Procedures and paperwork needed for Declaration of Conformity.
Click here for more information.
Source: AdvaMed
Latest from Today's Medical Developments
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
- The compact, complex capabilities of photochemical etching
- Moticont introduces compact, linear voice coil motor
- Manufacturing technology orders reach record high in December 2025
